Tags: Drug.
Triplatin tetranitrate (rINN; also known as BBR3464) is a platinum-based cytotoxic drug that underwent clinical trials for the treatment of human cancer. The drug acts by forming adducts with cellular DNA preventing DNA transcription and replication thereby inducing apoptosis. Other platinum-containing anticancer drugs include cisplatin carboplatin and oxaliplatin.
